在不安四肢综合征中,中心和周围刺激性
Amedeo De Grado1,2,3,4, Gaia Fanella5,6, James Howells7
1Neurophysiology Unit, Fondazione IRCCS Istituto Neurologico 'Carlo Besta', Milan, Italy.
Brain communications
|January 12, 2026
概括
不安腿综合征 (RLS) 涉及神经刺激性变化,包括减少皮内抑制和改变感觉运动整合,即使在不受影响的手部区域. 轴突刺激性测试表明,高极化激活电流可能导致RLS症状.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生理学 生理学 生理学
背景情况:
- 不安腿综合征 (RLS) 影响到10%的人口,但其潜在机制尚不清楚.
- 神经生理刺激性测试为RLS的感觉运动集成,离子通道功能和神经抑制提供了一个窗口.
- 评估中枢神经系统 (CNS) 和外周神经系统 (PNS) 的刺激性,可以全面了解神经参与.
研究的目的:
- 通过检查皮质,脊柱和外围神经功能来研究RS患者中广泛存在的中枢神经系统和脑后神经系统刺激性变化.
- 在RLS中探索潜在的神经机制,包括传感运动集成和轴突离子通道功能障碍.
- 分析RLS患者的手肌刺激性,提供超出通常受影响的下肢的洞察力.
主要方法:
- 值跟踪的横磁刺激 (TMS) 评估了皮质刺激性 (短间隔和长间隔的皮质内抑制).
- 长潜反射 (LLRs) 测量了感觉运动整合;F波,H反射和RIII反射评估了脊髓刺激性.
- 扩展的TRONDNF协议检查了轴突刺激性.
主要成果:
- 在RLS患者中观察到短间隔内皮层抑制 (SICI) 和长间隔内皮层抑制 (LICI) 的降低,特别是在M1手部区域.
- 长潜反射 (LLR) 的第二个组成部分的扩展幅度增加,在引肌 (abductor pollicis brevis) 肌肉中,表明感觉运动整合发生变化.
- 轴突刺激性测试显示,高极化激活电流的分级增加与RLS症状严重程度相关.
结论:
- 在RLS中减少皮质内抑制表明皮质功能障碍,即使在临床上不受影响的大脑区域.
- 在皮质层面改变感觉运动整合与RLS病理生理学有关.
- 超极化激活电流可能在RLS症状的发展或倾向中发挥作用.
相关概念视频
Restless Leg Syndrome and Night Terrors
473
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
473
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
4.5K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.5K
Local Anesthetics: Differential Sensitivity of Nerve Fibers
1.3K
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.3K
REM Sleep Behavior Disorder
1.3K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
1.3K
Centrally Acting Muscle Relaxants: Therapeutic Uses
1.2K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.2K
Drugs Acting on Autonomic Ganglia: Stimulants
2.0K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K


